April 14, 2021
Business News

VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021


CAMBRIDGE, Mass.–()–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced financial results for the fourth quarter and twelve months ended December 31, 2020. The Company also provided a corporate update and its outlook for 2021.

Annual Note from Jeff Baxter, President and CEO:

“2020 was, unfortunately, a historic year, marked by unprecedented disruption, with severe public health, societal, and economic consequence. Every single person, worldwide, felt the devastating effects of the ongoing COVID-19 pandemic. Industries and companies went through extraordinary change and, amidst the temporary…



Click here to view the original article.

Related Posts

You might also like ...

Personalized Loyalty Solutions Provider Exchange Solutions Raises Growth Funding
Polyneuron and University of Basel Awarded Grant of CHF 1.2M to Advance Novel Treatments to Support ABO-Incompatible Transplants
The Hundred Club of Massachusetts Announces Affiliation with Home Base